Incorporation of beclomethasone dipropionate into polyethylene glycol-diacyl lipid micelles as a pulmonary delivery system

Drug Development Research

Volumn 73, Issue 2, 2012, Pages 90-105

  Sahib, Mohanad Naji ^a   Darwis, Yusrida ^a   Peh, Kok Khiang ^a   Abdulameer, Shaymaa Abdalwahed ^a   Fung Tan, Yvonne Tze ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

beclomethasone; nebulization; pulmonary delivery

Indexed keywords

BECLOMETASONE DIPROPIONATE; LONG ACTING DRUG; MACROGOL; PHOSPHATIDYLETHANOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; FOURIER TRANSFORMATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INFRARED SPECTROSCOPY; LUNG LAVAGE; MALE; MICELLE; NEBULIZATION; NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; RAT; ZETA POTENTIAL;

EID: 84859917003     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21000     Document Type: Article

References (72)

1. Abdulla J, Tan Y, Darwis Y,. 2010. Rehydrated lyophilized rifampicin-loaded mPEG-DSPE formulations for nebulization. AAPS PharmSciTech 11: 663-671.
2. Adams E, Coomans D, Smeyers-Verbeke J, Massart D,. 2001. Application of linear mixed effects models to the evaluation of dissolution profiles. Int J Pharm 226: 107-125. (Pubitemid 32800787)
3. Adcock IM, Caramori G, Chung KF,. 2008. New targets for drug development in asthma. Lancet 372: 1073-1087.
4. Aliabadi HM, Elhasi S, Mahmud A, Gulamhusein R, Mahdipoor P, Lavasanifar A,. 2007. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading. Int J Pharm 329: 158-165. (Pubitemid 44937525)
5. Amani A, York P, Chrystyn H, Clark B,. 2010. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech 11: 1147-1151.
6. Andersson SE, Zackrisson C, Behrens K, Hemsen A, Forsberg K, Linden M, Lundberg JM,. 1995. Effect of allergen provocation on inflammatory cell profile and endothelin-like immunoreactivity in guinea-pig airways. Allergy 50: 349-358.
7. Arias MJ, Moyano JR, Ginés JM,. 1998. Study by DSC and HSM of the oxazepam-PEG 6000 and oxazepam-D-mannitol systems: application to the preparation of solid dispersions. Thermochim Acta 321: 33-41. (Pubitemid 128351777)
8. Barnes P,. 1995. Inhaled glucocorticoids for asthma. N Engl J Med 332: 868-875.
9. Batavia R, Taylor KMG, Craig DQM, Thomas M,. 2001. The measurement of beclomethasone dipropionate entrapment in liposomes: a comparison of a microscope and an HPLC method. Int J Pharm 212: 109-119. (Pubitemid 32121956)
10. Berger W,. 2009. Aerosol devices and asthma therapy. Curr Drug Deliv 6: 38-49.
11. Cerasoli F,. 2006. Developing the ideal inhaled corticosteroid. Chest 130: 54S-64S.
12. Cesur H, Rubinstein I, Pai A, Ã-nyüksel H,. 2009. Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer. Nanomed 5: 178-183.
13. Chanoine F, Grenot C, Heidmann P, Junien JL,. 1991. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments. Drug Metab Dispos 19: 546-553.
14. Chiang PC, Hu Y, Blom JD, Thompson DC,. 2010. Evaluating the suitability of using rat models for preclinical efficacy and side effects with inhaled corticosteroids nanosuspension formulations. Nanoscale Res Lett 5: 1010-1019.
15. Chow SC, Fanny YK,. 1997. Statistical comparison between dissolution profiles of drug products. J Biopharm Stat 7: 241-258.
16. Coombes A, Tasker S, Lindblad M, Holmgren J, Hoste K, Toncheva V, Schacht E, Davies M, Illum L, Davis S,. 1997. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly (ethylene glycol) anchoring segments. Biomaterials 18: 1153-1161. (Pubitemid 27346091)
17. Costa F, Sousa J, Pais A, Formosinho S,. 2003. Comparison of dissolution profiles of ibuprofen pellets. J Control Release 89: 199-212. (Pubitemid 36507015)
18. Dailey LA, Schmehl T, Gessler T, Wittmar M, Grimminger F, Seeger W, Kissel T,. 2003. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. J Control Release 86: 131-144. (Pubitemid 35461980)
19. Darwis Y, Kellaway IW,. 2001. Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes. Int J Pharm 215: 113-121. (Pubitemid 32206609)
20. Davies DE,. 2009. The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc 6: 678-682.
21. Davies NM, Feddah MR,. 2003. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm 255: 175-187. (Pubitemid 36369601)
22. Derakhshandeh K, Soheili M, Dadashzadeh S, Saghiri R,. 2010. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients. Int J Nanomedicine 5: 463-471.
23. Falamarzian A, Lavasanifar A,. 2010. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly([var epsilon]-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B. Colloids Surf B Biointerfaces 81: 313-320.
24. Fidler I, Raz A, Fogler W, Kirsh R, Bugelski P, Poste G,. 1980. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res 40: 4460-4466. (Pubitemid 11199705)
25. Field AP,. 2009. Correlation. In:, Field AP, editor. Discovering statistics using SPSS: (and sex and drugs and rock "n" roll). New Delhi: SAGE publications Ltd, p 107-157.
26. Foe K, Brown KF, Seale JP,. 2000. Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma. J Pharm Sci 89: 1143-1150.
27. Freiwald M, Valotis A, Kirschbaum A, Mcclellan M, Murdter T, Fritz P, Friedel G, Thomas M, Hogger P,. 2005. Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model. Respir Res 6: 21.
28. Gaucher G, Dufresne M-H, Sant VP, Kang N, Maysinger D, Leroux J-C,. 2005. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 109: 169-188. (Pubitemid 41742123)
29. Gill KK, Nazzal S, Kaddoumi A,. 2011. Paclitaxel loaded PEG5000-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation. Eur J Pharm Biopharm 79: 276-284.
30. Gonjari ID, Karmarkar AB, Hosmani A,. 2009. Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. Dig J Nanomater Bio s 4: 651-661.
31. Gozzard N,. 1996. Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits. Br J Pharmacol 118: 1201-1208. (Pubitemid 26235619)
32. Green C, Knight J, Precious S, Simpkin S,. 1981. Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience. Lab Anim 15: 163-170. (Pubitemid 11073500)
33. Hochhaus G, Mollmann H, Derendorf H, Gonzalez-Rothi R,. 1997. Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model. J Clin Pharmacol 37: 881-892. (Pubitemid 27514906)
34. Hyvönen S, Peltonen L, Karjalainen M, Hirvonen J,. 2005. Effect of nanoprecipitation on the physicochemical properties of low molecular weight poly(l-lactic acid) nanoparticles loaded with salbutamol sulphate and beclomethasone dipropionate. Int J Pharm 295: 269-281. (Pubitemid 40558809)
35. Koo OM, Rubinstein I, Onyuksel H,. 2005. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Nanomed 1: 77-84. (Pubitemid 43963604)
36. Korsgren M,. 1997. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185: 885-892. (Pubitemid 27119872)
37. Leung SY, Williams AS, Nath P, Dinh QT, Oates T, Blanc FX, Eynott PR, Chung KF,. 2008. Dose-dependent inhibition of allergic inflammation and bronchial hyperresponsiveness by budesonide in ovalbumin-sensitised Brown-Norway rats. Pulm Pharmacol Ther 21: 98-104.
38. Lim SB, Rubinstein I, Ã-nyüksel H,. 2008. Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles. Int J Pharm 356: 345-350.
39. Lukyanov AN, Torchilin VP,. 2004. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 56: 1273-1289. (Pubitemid 38510474)
40. Marsh D, Bartucci R, Sportelli L,. 2003. Lipid membranes with grafted polymers: physicochemical aspects. Biochim Biophys Acta 1615: 33-59. (Pubitemid 37013466)
41. Matsuo Y, Ishihara T, Ishizaki J, Miyamoto K, Higaki M, Yamashita N,. 2009. Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol 260: 33-38.
42. Mikhail AS, Allen C,. 2009. Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. J Control Release 138: 214-223.
43. O'hara T, Dunne A, Butler J, Devane J,. 1998. A review of methods used to compare dissolution profile data. Pharm Sci Technol Today 1: 214-223. (Pubitemid 28387122)
44. Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S,. 2009. In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine a for inhalation therapy. J Control Release 138: 16-23.
45. Ã-nyüksel H, Mohanty PS, Rubinstein I,. 2009. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer. Int J Pharm 365: 157-161.
46. Opanasopit P, Ngawhirunpat T, Chaidedgumjorn A, Rojanarata T, Apirakaramwong A, Phongying S, Choochottiros C, Chirachanchai S,. 2006. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system. Eur J Pharm Biopharm 64: 269-276. (Pubitemid 44585206)
47. Ostrander K, Bosch H, Bondanza D,. 1999. An in-vitro assessment of a NanoCrystal (TM) beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization. Eur J Pharm Biopharm 48: 207-215. (Pubitemid 29509787)
48. Polli JE, Rekhi GS, Augsburger LL, Shah VP,. 1997. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci 86: 690-700. (Pubitemid 27248819)
49. Rijcken CJF, Soga O, Hennink WE, Nostrum CFV,. 2007. Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release 120: 131-148. (Pubitemid 47058635)
50. Sahib MN, Darwis Y, Khiang PK, Tan YTF,. 2010. Aerodynamic characterization of marketed inhaler dosage forms: high performance liquid chromatography assay method for the determination of budesonide. Afr J Pharm Pharmacol 4: 878-884.
51. Sahib MN, Darwis Y, Khiang PK,. 2011. Aerodynamic characterization of beclomethasone dipropionate from beclate-50 inhaler® by HPLC-UV. J Liq Chromatogr Relat Technol 34: 613-621.
52. Sakagami M, Kinoshita W, Sakon K, Sato J, Makino Y,. 2002. Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation. J Control Release 80: 207-218. (Pubitemid 34273760)
53. Salzman G, Pyszczynski D,. 1988. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol 81: 424-428. (Pubitemid 18060235)
54. Sezgin Z, Yüksel N, Baykara T,. 2006. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm 64: 261-268. (Pubitemid 44585209)
55. Sezgin Z, Yuksel N, Baykara T,. 2007. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. Int J Pharm 332: 161-167. (Pubitemid 46227770)
56. Smaldone G, Cruz-Rivera M, Nikander K,. 1998. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 11: 113-125. (Pubitemid 28259491)
57. Smola M, Vandamme T, Sokolowski A,. 2008. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomedicine 3: 1-19. (Pubitemid 351517072)
58. Stenton G, Ulanova M, Déry R, Merani S, Kim M, Gilchrist M, Puttagunta L, Musat-Marcu S, James D, Schreiber A,. 2002. Inhibition of allergic inflammation in the airways using aerosolized antisense to syk kinase. J Immunol 169: 1028-1036. (Pubitemid 34753463)
59. Stoeck M, Riedel R, Hochhaus G, Häfner D, Masso JM, Schmidt B, Hatzelmann A, Marx D, Bundschuh D,. 2004. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 309: 249-258. (Pubitemid 38393137)
60. Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M,. 2005. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm 59: 57-62. (Pubitemid 39573437)
61. Vaghi A, Berg E, Liljedahl S, Svensson JO,. 2005. In vitro comparison of nebulised budesonide (Pulmicort Respules®) and beclomethasone dipropionate (Clenil® per aerosol). Pulm Pharmacol Ther 18: 151-153. (Pubitemid 40092666)
62. Vangeyte P, Gautier S, Jérôme R,. 2004. About the methods of preparation of poly(ethylene oxide)-b-poly([epsilon]-caprolactone) nanoparticles in water: analysis by dynamic light scattering. Colloids Surf A Physicochem Eng Asp 242: 203-211. (Pubitemid 38981591)
63. Waldrep J, Arppe J, Jansa K, Knight V,. 1997. High dose cyclosporin A and budesonide-liposome aerosols. Int J Pharm 152: 27-36. (Pubitemid 27254958)
64. Waldrep JC, Arppe J, Jansa KA, Vidgren M,. 1998. Experimental pulmonary delivery of cyclosporin a by liposome aerosol. Int J Pharm 160: 239-249. (Pubitemid 28083097)
65. Wiggins NA,. 1991. The development of a mathematical approximation technique to determine the mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD) of drug particles in an inhalation aerosol sprat. Drug Dev Ind Pharm 17: 1971-1986.
66. Yang W, Peters JI, Williams RO III,. 2008a. Inhaled nanoparticles-A current review. Int J Pharm 356: 239-247.
67. Yang ZL, Li XR, Yang KW, Liu Y,. 2008b. Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: preparation, freeze-drying, and in vitro release. J Biomed Mater Res A 85A: 539-546. (Pubitemid 351535336)
68. Yuksel N, Kanik AE, Baykara T,. 2000. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and-independent methods. Int J Pharm 209: 57-67.
69. Zhang JX, Li XJ, Qiu LY, Li XH, Yan MQ, Yi J, Zhu KJ,. 2006. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: preparation, in vitro and in vivo evaluation. J Control Release 116: 322-329. (Pubitemid 44827410)
70. Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH,. 2004. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co- lactide) nanoparticles and their biodistribution in mice. J Control Release 96: 135-148. (Pubitemid 38438496)
71. Zhang X, Jackson JK, Burt HM,. 1996. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 132: 195-206. (Pubitemid 26158719)
72. Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, Xie S,. 2010. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12: 263-271.